ANJI

What this means for you

This application is over — abandoned 08 Apr 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

90843473

Mark type

Stylized text

Filed

22 Jul 2021

Published for opposition

10 Jan 2023

Abandoned

08 Apr 2024

Attorney of record

Nicole Kinsley, Esq.

Goods and services

• Class 005 — Pharmaceuticals: House mark for a full line of pharmaceutical preparations for human use; pharmaceutical preparations for human use for treatment and prevention of inflammatory, oncological, autoimmune, genetic, neurological, metabolic, infectious, hematological, musculo-skeletal, degenerative, cardiovascular, respiratory, gastrointestinal, endocrinological, dermatological, genitourinary, ophthalmological, hepatic, and nephrological diseases and conditions; pharmaceutical preparations for human use for treatment and prevention of pain; pharmaceutical preparations for human use for treatment and prevention of allergies

Owner

• Anji Pharmaceuticals Inc., Cambridge, MA, KY
• Anji Pharmaceuticals Inc., Cambridge, MA, KY

Prosecution history

• 08 Apr 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
• 08 Apr 2024 — ABANDONMENT - NO USE STATEMENT FILED
• 09 Aug 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 07 Aug 2023 — SOU EXTENSION 1 GRANTED
• 07 Aug 2023 — SOU EXTENSION 1 FILED
• 07 Aug 2023 — SOU TEAS EXTENSION RECEIVED
• 30 Jun 2023 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
• 30 Jun 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
• 30 Jun 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
• 30 Jun 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
• 07 Mar 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 10 Jan 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 10 Jan 2023 — PUBLISHED FOR OPPOSITION
• 21 Dec 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 08 Dec 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER